Evaluating cost and resource use associated with pulse oximetry screening for critical congenital heart disease: Empiric estimates and sources of variation
Matthew R. Reeder(Cleveland Clinic), Lorenzo D. Botto(Centers for Disease Control and Prevention), Amy Nance(Utah Department of Health), Marcia L. Feldkamp(University of Utah), Harper Randall(Utah Department of Health), Sergey Krikov(University of Utah), Jaewhan Kim(University of Utah)
Cited by 16
Related Papers
Racial and Temporal Variations in the Prevalence of Heart Defects
|PEDIATRICS|2001|575
Mortality Associated With Congenital Heart Defects in the United States
|Circulation|2001|567
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies
|Birth Defects Research Part A Clinical and Molecular Teratology|2007|464
Utah Growth Study: Growth standards and the prevalence of growth hormone deficiency
|The Journal of Pediatrics|1994|429
Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002
|Circulation|2006|336